IMAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
IMAX Corp is currently not an optimal buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company shows strong revenue growth and positive analyst sentiment, the overbought technical indicators, insider selling, and potential near-term price correction suggest waiting for a better entry point.
The technical indicators show a bullish trend with MACD positively expanding and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 82.669, indicating the stock is overbought. Key resistance levels are at R1: 41.139 and R2: 42.835, with support levels at S1: 35.647 and S2: 33.95.
Record global box office revenue of $1.28 billion in 2025, a 40% increase YoY.
Q4 revenue growth of 35.1% YoY and adjusted EPS exceeding expectations by $0.
Strong analyst sentiment with multiple price target upgrades, reflecting confidence in the company's growth potential.
Bullish multi-year growth outlook driven by a diversified content pipeline and expanding market share.
Insider selling has increased by 585.13% over the last month, signaling potential lack of confidence from insiders.
Congress trading data shows no recent activity, indicating no influential political backing.
The stock is overbought based on RSI, suggesting a potential near-term price correction.
Options data indicates bearish sentiment with high put-call ratios.
In Q4 2025, IMAX reported a 35.11% YoY increase in revenue to $125.2 million. However, net income dropped by 87.99% YoY to $637,000, and EPS fell by 90% to $0.01. Gross margin improved to 55.96%, up 10.77% YoY, reflecting operational efficiency despite declining profitability.
Analysts are overwhelmingly positive on IMAX, with multiple upgrades and price target increases. The average price target is around $46-$48, with analysts citing strong growth prospects, a robust film slate, and expanding market share as key drivers.
